PRTA

Prothena Public Stock Analysis

AI Rating

Low
  • Quality1/10
  • Growth↑ 5/10
  • Value↓ 0/10
Prothena Public sales and earnings growth
PRTA Growth
Neutral
  • Revenue Y/Y↓ -57.99%
  • EPS Y/Y↓ -37.07%
  • FCF Y/Y↑ 37.64%
Prothena Public gross and profit margin trends
PRTA Profitability
Low
  • Gross margin ↑ 100.00%
  • EPS margin↓ -260.90%
  • ROIC 5Y↑ -605.08%
Prothena Public net debt vs free cash flow
PRTA Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Prothena Public stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Biotechnology stocks